DCC
NUVA

Dow Chemical Company’s NuVasive, Inc. NUVA Stock Holding History

Dow Chemical Company’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-41,800
Closed -$1.61M – 99
2014
Q1 		$1.61M Hold
41,800
– – 0.13% 65
2013
Q4 		$1.35M Hold
41,800
– – 0.11% 60
2013
Q3 		$1.02M Sell
41,800
-25,000
-37% -$615K 0.09% 54
2013
Q2 		$1.66M Buy
+66,800
New +$1.46M 0.15% 45

Other funds holding NUVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dow Chemical Company's NUVA Position: Q2 2014 in Review

Dow Chemical Company sold out of NuVasive, Inc. (NUVA) in Q2 2014, closing a stake of 41,800 shares — an estimated $1.61M sold.

Dow Chemical Company first reported a position in NUVA in Q2 2013 and held it in 4 quarters. The position peaked at $1.66M in Q2 2013. 177 funds tracked by Wall St. Rank hold NUVA as of Q2 2014.

  • Dow Chemical Company reported no remaining NuVasive, Inc. position as of Q2 2014 after selling out during the quarter.
  • Dow Chemical Company sold 41,800 NuVasive, Inc. shares in Q2 2014, an estimated $1.61M.
  • Dow Chemical Company first reported a position in NuVasive, Inc. in Q2 2013 and held it in 4 quarters.
  • Dow Chemical Company's NuVasive, Inc. position peaked at $1.66M in Q2 2013.
  • 177 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2014.

Based on Dow Chemical Company's 13F filing for Q2 2014, filed 11 Aug 2014.